ERBB2 and breast cancer: A subgroup analysis showed that preoperative SUVmax was significantly higher in patients with RD compared to those with pCR across different BC subtypes (p = 0.011 for HR+/HER2-, p = 0.0015 for HR-/HER2+, and p = 0.0004 for TNBC).